On May 26, 2020, Blonder Tongue Laboratories, Inc. announced that Robert J. Pallé, who served as the Company’s Chief Executive Officer and President during 2019 and was a “named executive officer” for that year, executed a letter agreement (the “Agreement”) providing for the continued employment of Mr. Pallé by the Company in a new role as Managing Director—Strategic Accounts, reporting to the Company’s CEO. Mr. Pallé also continues his service as a member of the Company’s Board of Directors (the “Board”). Under the Agreement, which the parties have agreed will have an effective date of January 1, 2020, Mr. Pallé initially will be responsible for managing certain strategic customer and supplier accounts and leading certain specific initiatives and programs. The scope of his duties will be subject to change from time to time as determined by the Chief Executive Officer and/or the Board. . His employment will be on an “at will” basis, and he will be required to devote no more than 25 hours per week to fulfilling his duties under the Agreement. The health, life and disability insurance and other benefits currently in effect for Mr. Pallé will continue in effect through December 31, 2020, assuming that he continue to remain eligible for such benefits, and will be subject to modification only to the extent that the Company modifies such benefits for all senior-level Company employees. The parties anticipate that Mr. Pallé’s employment will terminate on December 31, 2020 unless otherwise extended by the parties.